Onset of Marine-Lenhart syndrome and Graves' ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis.

CONCLUSION: We present a case of Graves' disease with active, moderate-to-severe Graves' ophthalmopathy in a patient with pre-existing AFTN presenting with a coexisting, rare case of Marine-Lenhart syndrome associated with immune reconstitution after alemtuzumab treatment. PMID: 32500462 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32500462?dopt=Abstract

Source: Hormones - June 6, 2020 Category: Endocrinology Tags: Hormones (Athens) Source Type: research